Miller, J. J., Gonzalez Castro, L. N., McBrayer, S., Weller, M., Cloughesy, T., Portnow, J., Andronesi, O., Barnholtz-Sloan, J. S., Baumert, B. G., Berger, M. S., Bi, W. L., Bindra, R., Cahill, D. P., Chang, S. M., Costello, J. F., Horbinski, C., Huang, R. Y., Jenkins, R. B., Ligon, K. L., Mellinghoff, I. K., Nabors, L. B., Platten, M., Reardon, D. A., Shi, D. D., Schiff, D., Wick, W., Yan, H., von Deimling, A., van den Bent, M., Kaelin, W. G., & Wen, P. Y. (2023). isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-oncology, 25(1), 4–25. http://access.bl.uk/ark:/81055/vdc_100174250362.0x00001b